martes, 31 de enero de 2012

Menos mal que vamos mal (VI) / Top 10 "Big Pharma" en los Fondos de inversión alternativa ("Hedge Funds")

Drug companies are non-cyclical stocks that do relatively well during bear markets. They used to be growth stocks too. Top pharmaceutical companies had a 7.1% growth rate between 2003 and 2009. However, the average growth rate is expected to fall to 1.3% by 2015. Nevertheless, these stocks yield more than long-term Treasuries. The top three most popular stocks yield around 3.5% annually.

We believe these stocks are great dividend plays and are also likely to deliver capital gains to their investors over the next few years. We use hedge fund positions in each stock as a proxy for each stock’s potential. Our research has shown that the stocks most favored by hedge funds performed better than the market over the past decade. (Más)

Ver anterior:

No hay comentarios: